The fabrication and characterization of a PLGA nanoparticle–Pheroid® combined drug delivery system
- 503 Downloads
The combination of polymeric nanoparticles (NPs) as a core and lipid vesicles as a shell has emerged to be a robust and promising drug delivery strategy. This study explores the development of a novel combined delivery system where poly d,l, lactic-co-glycolic acid (PLGA) NPs are entrapped within Pheroid® drug delivery system. The solid NPs were combined with the Pheroid® vesicles using two different methods: pre-mix and post-mix. The surface properties of the PLGA NPs were altered through the inclusion (pos-NPs) and exclusion (neg-NPs) of chitosan (CT) and polyethylene glycol (PEG), to evaluate their interaction with the Pheroid® Vesicles. The average particle size of the novel NP–Pheroid® combined system ranged from approximately 1990–2450 nm while the zeta potential (ZP) ranged from −18 to −30 mV, measured using dynamic light scattering (DLS) and electrophoretic velocity techniques, respectively. The NP/Pheroid® mixing ratio experiment indicated that a maximum of 2.5% (w/v) NPs can be optimally added to the Pheroid® vesicles without compromising the structure and the stability of the NP–Pheroid® combined system. Visual analysis of this system was done through transmission electron microscopy (TEM), cryogenic (cryo) TEM and confocal laser scanning microscopy (CLSM) techniques to obtain adequate information of this novel combined drug delivery system which includes the localization of the PLGA NPs with the Pheroid ® vesicles.
KeywordsChitosan Zeta Potential Dynamic Light Scattering Dynamic Light Scattering Combine System
The authors would like to thank the National Research Foundation (NRF) and the Department of Science and Technology (DST) for financial support. The authors also thank Dr Matthew Glyn for his technical assistance with the CLSM.
- 4.Saroj S, Baby DA, Sabitha M (2012) Current trends in lipid based delivery systems and its applications in drug delivery. Asian J Pharm Clin Res 5:4–9Google Scholar
- 5.Uys CE (2006) Preparation and characterization of Pheroids. Department of Pharmacy, North-west University, PotchefstroomGoogle Scholar
- 6.Grobler, AF. Pharmaceutical applications of Pheroid™ technology, Pharmacy, North-West University, Potchefstroom, 2008Google Scholar
- 8.Nieuwoudt L-M (2009) The impact of Pheroid™ technology on the bioavailability and efficacy of anti-tuberculosis drugs in an animal model/L. North-West University, NieuwoudtGoogle Scholar
- 14.Mufamadi MS, Pillay V, Choonara YE, Du Toit LC, Modi G, Naidoo D, Ndesendo VM. A review on composite liposomal technologies for specialized drug delivery. J Drug Deliv 2011;2011Google Scholar
- 21.Sollohub K, Cal K (2009) Spray drying technique: II. Current applications in pharmaceutical technology. J Pharm Sci 9999:1–11Google Scholar
- 33.Leica EM Sample Preparation Contrasting. In: GmbH LM, editors. LEICA, Vienna, 2013Google Scholar
- 34.StainFile, Osmium Tetroxide 2015Google Scholar